The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
- PMID: 23186910
- PMCID: PMC3508199
- DOI: 10.1136/bmj.e7895
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
Abstract
Objectives: To examine the risk of atrial fibrillation in relation to the whole spectrum of thyroid function in a large cohort of patients.
Design: Population based cohort study of general practice patients identified by linkage of nationwide registries at the individual level.
Setting: Primary care patients in the city of Copenhagen.
Subjects: Registry data for 586,460 adults who had their thyroid function evaluated for the first time by their general practitioner during 2000-10 and who were without previously recorded thyroid disease or atrial fibrillation.
Main outcome measure: Poisson regression models used to estimate risk of atrial fibrillation by thyroid function.
Results: Of the 586,460 individuals in the study population (mean (SD) age 50.2 (16.9) years, 39% men), 562,461 (96.0%) were euthyroid, 1670 (0.3%) had overt hypothyroidism, 12,087 (2.0%) had subclinical hypothyroidism, 3966 (0.7%) had overt hyperthyroidism, and 6276 (1.0%) had subclinical hyperthyroidism. Compared with the euthyroid individuals, the risk of atrial fibrillation increased with decreasing levels of thyroid stimulating hormone (TSH) from high normal euthyroidism (incidence rate ratio 1.12 (95% CI 1.03 to 1.21)) to subclinical hyperthyroidism with reduced TSH (1.16 (0.99 to 1.36)) and subclinical hyperthyroidism with supressed TSH (1.41 (1.25 to 1.59)). Both overt and subclinical hypothyroidism were associated with a lower risk of atrial fibrillation.
Conclusion: The risk of atrial fibrillation was closely associated with thyroid activity, with a low risk in overt hypothyroidism, high risk in hyperthyroidism, and a TSH level dependent association with risk of atrial fibrillation across the spectrum of subclinical thyroid disease.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures
Comment in
-
Thyroid function: Thyroid dysfunction and risk of atrial fibrillation.Nat Rev Endocrinol. 2013 Feb;9(2):63. doi: 10.1038/nrendo.2012.239. Epub 2012 Dec 18. Nat Rev Endocrinol. 2013. PMID: 23296162 No abstract available.
-
[Are thyroid disorders a predisposition for atrial fibrillation?].Dtsch Med Wochenschr. 2013 Feb;138(7):296. Dtsch Med Wochenschr. 2013. PMID: 23520616 German. No abstract available.
Similar articles
-
Thyroid status, cardiovascular risk, and mortality in older adults.JAMA. 2006 Mar 1;295(9):1033-41. doi: 10.1001/jama.295.9.1033. JAMA. 2006. PMID: 16507804 Free PMC article.
-
Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.J Clin Endocrinol Metab. 2014 Jul;99(7):2372-82. doi: 10.1210/jc.2013-4184. Epub 2014 Mar 21. J Clin Endocrinol Metab. 2014. PMID: 24654753
-
Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation.Circulation. 2017 Nov 28;136(22):2100-2116. doi: 10.1161/CIRCULATIONAHA.117.028753. Epub 2017 Oct 23. Circulation. 2017. PMID: 29061566 Free PMC article. Review.
-
Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk.J Clin Endocrinol Metab. 2012 Mar;97(3):852-61. doi: 10.1210/jc.2011-1978. Epub 2012 Jan 11. J Clin Endocrinol Metab. 2012. PMID: 22238391
-
Effects of Thyroid Dysfunction and the Thyroid-Stimulating Hormone Levels on the Risk of Atrial Fibrillation: A Systematic Review and Dose-Response Meta-Analysis from Cohort Studies.Endocr Pract. 2022 Aug;28(8):822-831. doi: 10.1016/j.eprac.2022.05.008. Epub 2022 May 31. Endocr Pract. 2022. PMID: 35660465 Review.
Cited by
-
Predictive Value of Free Triiodothyronine in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.Rev Cardiovasc Med. 2022 Jun 24;23(7):230. doi: 10.31083/j.rcm2307230. eCollection 2022 Jul. Rev Cardiovasc Med. 2022. PMID: 39076896 Free PMC article.
-
Thyroid dysfunction in nonvalvular atrial fibrillation and clinical outcomes.Endocrine. 2024 Oct;86(1):239-245. doi: 10.1007/s12020-024-03838-9. Epub 2024 Apr 22. Endocrine. 2024. PMID: 38649647
-
Thyroid Dysfunction in Advanced Heart Failure Patients and Its Correlation with Amiodarone Therapy: A Two-Year Study.Biomedicines. 2024 Mar 3;12(3):567. doi: 10.3390/biomedicines12030567. Biomedicines. 2024. PMID: 38540180 Free PMC article.
-
Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.Eur Thyroid J. 2024 Apr 1;13(2):e230254. doi: 10.1530/ETJ-23-0254. Print 2024 Apr 1. Eur Thyroid J. 2024. PMID: 38377675 Free PMC article. Review.
-
Quality of care among patients diagnosed with atrial fibrillation in Greenland.Int J Circumpolar Health. 2024 Dec;83(1):2311965. doi: 10.1080/22423982.2024.2311965. Epub 2024 Feb 8. Int J Circumpolar Health. 2024. PMID: 38332615 Free PMC article.
References
-
- Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000;85:4701-05. - PubMed
-
- Faber J, Wiinberg N, Schifter S, Mehlsen J. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 2001;145:391-6. - PubMed
-
- Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007;167:928-34. - PubMed
-
- Heeringa J, Hoogendoorn EH, van der Deure WM, Hofman A, Peeters RP, Hop WC, et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 2008;168:2219-24. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical